Kuo-Ping Chiu
Top Science Biotechnologies, Inc., TaiwanTitle: 1DF-PCR application in otorhinolaryngological investigations
Abstract
1DF-PCR (one drop of body
fluid-PCR) is a novel biotechnology being able to directly amplify DNA (i.e.,
w/o pre-isolation of the DNA molecules) present in a tiny volume (< ~20 L)
of crude sample for further analysis by sequencing or other methods. The
unprecedented capability of 1DF-PCR is made possible by combining well-designed
adapter and optimized experimental protocol with effective reagents. Firstly,
the adapter molecules do not form dimers which would otherwise inhibit the
amplification of the target DNA. Secondly, a "single-tube procedure"
is implemented in the protocol to allow the user to complete the key part of
the experimental procedure in the same tube, i.e., no need to change buffer or
purify experimental intermediates during the key steps. By combining these
unique advantages with selected, effective reagents, we produce the 1DF-PCR kit
aiming to facilitate biomedical research and molecular diagnosis. Notice that,
since 1DF-PCR does not require pre-isolation of DNA, there is no pre-selection upon
the target DNA species and all DNA fragments are subjected to analysis. Taken
together, we believe that these advantages will make 1DF-PCR a robust product
suitable for otorhinolaryngological investigations, because small volumes of
body liquids are frequently encountered by otorhinolaryngologists.
Biography
Kuo-Ping Chiu completed his PhD
in microbiology from UC Davis and did postdoc at Harvard Medical School. His
industrial experiences include a 2-yrs experience working at Bio-Rad as an
R&D scientist and a 6-yrs experience working at Genome Institute of
Singapore to develop Paired-End Ditag (PED) (or Mate-Pair, MP) sequencing
library preparation strategy and to analyze various sequence data. He moved
back to Taiwan in 2008 to work for Academia Sinica (AS) and teach in a number
of universities. At AS, he developed a number of biotechnologies for biomedical
investigations, including 1DF-PCR, gene net-digital PCR and other related
technologies. He has published ~50 papers with diverse subjects in
international journals and is the inventor of ~10 patents. After decades
working in academia, he is now running a Biotech Company in Taiwan to continue
his interest in developing cutting-edge biotechnologies for the scientific
community.